Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients

Abstract Background Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shigeto Ishikawa, Yuto Teshima, Hiroki Otsubo, Takashi Shimazui, Taka-aki Nakada, Osamu Takasu, Kenichi Matsuda, Junichi Sasaki, Masakazu Nabeta, Takeshi Moriguchi, Takayuki Shibusawa, Toshihiko Mayumi, Shigeto Oda
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/77ce90465686422ba2455da473150e6e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:77ce90465686422ba2455da473150e6e
record_format dspace
spelling oai:doaj.org-article:77ce90465686422ba2455da473150e6e2021-11-14T12:15:56ZRisk prediction of biomarkers for early multiple organ dysfunction in critically ill patients10.1186/s12873-021-00534-z1471-227Xhttps://doaj.org/article/77ce90465686422ba2455da473150e6e2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12873-021-00534-zhttps://doaj.org/toc/1471-227XAbstract Background Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting patient outcomes and selecting treatment strategies. This study examined the accuracy of biomarkers, including interleukin (IL)-6, in predicting early MOD in critically ill patients compared with that of quick sequential organ failure assessment (qSOFA). Methods This was a multicenter observational sub-study. Five universities from 2016 to 2018. Data of adult patients with systemic inflammatory response syndrome who presented to the emergency department or were admitted to the intensive care unit were prospectively evaluated. qSOFA score and each biomarker (IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein, and procalcitonin [PCT]) level were assessed on Days 0, 1, and 2. The primary outcome was set as MOD on Day 2, and the area under the curve (AUC) was analyzed to evaluate qSOFA scores and biomarker levels. Results Of 199 patients, 38 were excluded and 161 were included. Patients with MOD on Day 2 had significantly higher qSOFA, SOFA, and Acute Physiology and Chronic Health Evaluation II scores and a trend toward worse prognosis, including mortality. The AUC for qSOFA score (Day 0) that predicted MOD (Day 2) was 0.728 (95% confidence interval [CI]: 0.651–0.794). IL-6 (Day 1) showed the highest AUC among all biomarkers (0.790 [95% CI: 0.711–852]). The combination of qSOFA (Day 0) and IL-6 (Day 1) showed improved prediction accuracy (0.842 [95% CI: 0.771–0.893]). The combination model using qSOFA (Day 1) and IL-6 (Day 1) also showed a higher AUC (0.868 [95% CI: 0.799–0.915]). The combination model of IL-8 and PCT also showed a significant improvement in AUC. Conclusions The addition of IL-6, IL-8 and PCT to qSOFA scores improved the accuracy of early MOD prediction.Shigeto IshikawaYuto TeshimaHiroki OtsuboTakashi ShimazuiTaka-aki NakadaOsamu TakasuKenichi MatsudaJunichi SasakiMasakazu NabetaTakeshi MoriguchiTakayuki ShibusawaToshihiko MayumiShigeto OdaBMCarticleCritically illInterleukinMultiple organ dysfunctionPredictive markerqSOFASpecial situations and conditionsRC952-1245Medical emergencies. Critical care. Intensive care. First aidRC86-88.9ENBMC Emergency Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Critically ill
Interleukin
Multiple organ dysfunction
Predictive marker
qSOFA
Special situations and conditions
RC952-1245
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Critically ill
Interleukin
Multiple organ dysfunction
Predictive marker
qSOFA
Special situations and conditions
RC952-1245
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Shigeto Ishikawa
Yuto Teshima
Hiroki Otsubo
Takashi Shimazui
Taka-aki Nakada
Osamu Takasu
Kenichi Matsuda
Junichi Sasaki
Masakazu Nabeta
Takeshi Moriguchi
Takayuki Shibusawa
Toshihiko Mayumi
Shigeto Oda
Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
description Abstract Background Shock and organ damage occur in critically ill patients in the emergency department because of biological responses to invasion, and cytokines play an important role in their development. It is important to predict early multiple organ dysfunction (MOD) because it is useful in predicting patient outcomes and selecting treatment strategies. This study examined the accuracy of biomarkers, including interleukin (IL)-6, in predicting early MOD in critically ill patients compared with that of quick sequential organ failure assessment (qSOFA). Methods This was a multicenter observational sub-study. Five universities from 2016 to 2018. Data of adult patients with systemic inflammatory response syndrome who presented to the emergency department or were admitted to the intensive care unit were prospectively evaluated. qSOFA score and each biomarker (IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein, and procalcitonin [PCT]) level were assessed on Days 0, 1, and 2. The primary outcome was set as MOD on Day 2, and the area under the curve (AUC) was analyzed to evaluate qSOFA scores and biomarker levels. Results Of 199 patients, 38 were excluded and 161 were included. Patients with MOD on Day 2 had significantly higher qSOFA, SOFA, and Acute Physiology and Chronic Health Evaluation II scores and a trend toward worse prognosis, including mortality. The AUC for qSOFA score (Day 0) that predicted MOD (Day 2) was 0.728 (95% confidence interval [CI]: 0.651–0.794). IL-6 (Day 1) showed the highest AUC among all biomarkers (0.790 [95% CI: 0.711–852]). The combination of qSOFA (Day 0) and IL-6 (Day 1) showed improved prediction accuracy (0.842 [95% CI: 0.771–0.893]). The combination model using qSOFA (Day 1) and IL-6 (Day 1) also showed a higher AUC (0.868 [95% CI: 0.799–0.915]). The combination model of IL-8 and PCT also showed a significant improvement in AUC. Conclusions The addition of IL-6, IL-8 and PCT to qSOFA scores improved the accuracy of early MOD prediction.
format article
author Shigeto Ishikawa
Yuto Teshima
Hiroki Otsubo
Takashi Shimazui
Taka-aki Nakada
Osamu Takasu
Kenichi Matsuda
Junichi Sasaki
Masakazu Nabeta
Takeshi Moriguchi
Takayuki Shibusawa
Toshihiko Mayumi
Shigeto Oda
author_facet Shigeto Ishikawa
Yuto Teshima
Hiroki Otsubo
Takashi Shimazui
Taka-aki Nakada
Osamu Takasu
Kenichi Matsuda
Junichi Sasaki
Masakazu Nabeta
Takeshi Moriguchi
Takayuki Shibusawa
Toshihiko Mayumi
Shigeto Oda
author_sort Shigeto Ishikawa
title Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_short Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_full Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_fullStr Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_full_unstemmed Risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
title_sort risk prediction of biomarkers for early multiple organ dysfunction in critically ill patients
publisher BMC
publishDate 2021
url https://doaj.org/article/77ce90465686422ba2455da473150e6e
work_keys_str_mv AT shigetoishikawa riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT yutoteshima riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT hirokiotsubo riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT takashishimazui riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT takaakinakada riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT osamutakasu riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT kenichimatsuda riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT junichisasaki riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT masakazunabeta riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT takeshimoriguchi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT takayukishibusawa riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT toshihikomayumi riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
AT shigetooda riskpredictionofbiomarkersforearlymultipleorgandysfunctionincriticallyillpatients
_version_ 1718429354623500288